Join
Live feed
·
PRReleasevia Quantisnow
Exscientia Plc logo
Recursion Pharmaceuticals Inc. logo

Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EXAI (Exscientia Plc), RXRX (Recursion Pharmaceuticals Inc.) and more on Quantisnow.